Cargando…

Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a common digestive tract malignant tumor with high incidence and dismal prognosis worldwide. However, the reliable biomarkers for clinical diagnosis and the underlying signaling pathways insights of ESCC are not unequivocally understood yet. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenhu, Wang, Qiang, Chang, Jinxia, Bhetuwal, Anup, Bhattarai, Nisha, Zhang, Fan, Tang, Jiancai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128263/ https://www.ncbi.nlm.nih.gov/pubmed/35610567 http://dx.doi.org/10.1186/s12014-022-09357-x

Ejemplares similares

Circulatory Metabolomics Reveals the Association of the Metabolites With Clinical Features in the Patients With Intrahepatic Cholestasis of Pregnancy
por: Liu, Wenhu, et al.
Publicado: (2022)

Metabolic pathways underlying GATA6 regulating Trastuzumab resistance in Gastric Cancer cells based on untargeted metabolomics
por: Chang, Jinxia, et al.
Publicado: (2020)

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
por: Wang, Wenjian, et al.
Publicado: (2017)

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

CT-Guided Core Needle Biopsy of Pleural Lesions: Evaluating Diagnostic Yield and Associated Complications
por: Niu, Xiang-Ke, et al.
Publicado: (2015)

Unveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer’s Disease
por: Jain, Mukul, et al.
Publicado: (2023)

Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma
por: Chang, Chen, et al.
Publicado: (2021)

The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma
por: Huang, Xinyi, et al.
Publicado: (2019)

Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins
por: O'Neill, J. Robert, et al.
Publicado: (2017)

Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
por: Rao, Dingyu, et al.
Publicado: (2023)

Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches
por: Popescu, Ionela Daniela, et al.
Publicado: (2014)

Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis
por: Zhu, Xi, et al.
Publicado: (2010)

Diagnostic value of serum human epididymis protein 4 in esophageal squamous cell carcinoma
por: Liu, Shi-Yuan, et al.
Publicado: (2020)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

Immune Infiltration Represents Potential Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Li, Mengxiang, et al.
Publicado: (2022)

Lymphatic filarial serum proteome profiling for identification and characterization of diagnostic biomarkers
por: Kumar, Vipin, et al.
Publicado: (2022)

Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
por: Gao, She-Gan, et al.
Publicado: (2018)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
por: Lin, Zheng, et al.
Publicado: (2022)

Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
por: Yan, Ting, et al.
Publicado: (2019)

A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma
por: Lv, Jiali, et al.
Publicado: (2021)

Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022)

High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2023)

Global metabolomic profiling of trastuzumab resistant gastric cancer cells reveals major metabolic pathways and metabolic signatures based on UHPLC-Q exactive-MS/MS
por: Liu, Wenhu, et al.
Publicado: (2019)

Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms
por: Satoh, Kazumi, et al.
Publicado: (2013)

Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis
por: Kimura, Yayoi, et al.
Publicado: (2017)

Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer
por: Liu, Wenhu, et al.
Publicado: (2018)

Unveiling the Trypanosoma cruzi Nuclear Proteome
por: dos Santos Júnior, Agenor de Castro Moreira, et al.
Publicado: (2015)

Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing
por: Xing, Shan, et al.
Publicado: (2017)

Esophagitis Dissecans Superficialis: Unveiling the Enigmatic Entity of Esophageal Mucosal Sloughing
por: Qasim, Abeer, et al.
Publicado: (2023)

Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma
por: Yuan, Qiang, et al.
Publicado: (2019)

Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis
por: Yu, Shao-Bin, et al.
Publicado: (2017)

Unveiling the prognostic significance of SOX5 in esophageal squamous cell carcinoma: a comprehensive bioinformatic and experimental analysis
por: Li, Chenglin, et al.
Publicado: (2023)

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2017)

Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Cui, Yuantao, et al.
Publicado: (2017)

Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma
por: Jiao, Zichen, et al.
Publicado: (2020)

Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling
por: OKANO, TETSUYA, et al.
Publicado: (2016)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

CKAP2L Promotes Esophageal Squamous Cell Carcinoma Progression and Drug-Resistance by Modulating Cell Cycle
por: Chen, Wenhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gv6ck7g7j3kdjdvmdvlb77j7v3